基本信息
views: 1011
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Analysis of clinical trials with correlative laboratory data
Analysis of laboratory and animal data
There exists a substantial statistical literature exists on the design and analysis of clinical trials with response or time-to-event end points. However, early-stage trials with biologic end points, such as vaccine studies or investigations of targeted therapies, require alternative approaches. It is crucial that in the planning stage, the unique aspects of a biologic or molecular therapy be taken into account. This principle extends to the design of laboratory studies, and especially to those correlative laboratory studies that embedded in clinical investigations.
An aspect of the complexity of laboratory studies—whether in basic science, animals, or humans--is the abundance of data. With the advent of whole genome or whole exome sequencing in conjunction with epigenetic or proteomic studies on the same patient, the number of laboratory values collected far exceeds the number of patients. Dr. Neuberg's current interests concern the planning and analysis of studies that integrate laboratory outcomes at the genome, transcriptome, or proteome level with clinical and demographic information.
Analysis of laboratory and animal data
There exists a substantial statistical literature exists on the design and analysis of clinical trials with response or time-to-event end points. However, early-stage trials with biologic end points, such as vaccine studies or investigations of targeted therapies, require alternative approaches. It is crucial that in the planning stage, the unique aspects of a biologic or molecular therapy be taken into account. This principle extends to the design of laboratory studies, and especially to those correlative laboratory studies that embedded in clinical investigations.
An aspect of the complexity of laboratory studies—whether in basic science, animals, or humans--is the abundance of data. With the advent of whole genome or whole exome sequencing in conjunction with epigenetic or proteomic studies on the same patient, the number of laboratory values collected far exceeds the number of patients. Dr. Neuberg's current interests concern the planning and analysis of studies that integrate laboratory outcomes at the genome, transcriptome, or proteome level with clinical and demographic information.
Research Interests
Papers共 1299 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Genes & developmentno. 5-6 (2024): 289-289
Gregory H Bird,J J Patten,William Zavadoski,Nicole Barucci,Marina Godes, Benjamin M Moyer, Callum D Owen,Paul DaSilva-Jardine,Donna S Neuberg,Richard A Bowen,Robert A Davey,Loren D Walensky
Nature communicationsno. 1 (2024): 274-274
Natureno. 8015 (2024): 198-205
Leukemiano. 7 (2024): 1-7
bioRxiv the preprint server for biology (2024)
Leukemiano. 4 (2024): 1-7
Yang C. Zeng, Olivia J. Young,Christopher M. Wintersinger,Frances M. Anastassacos,James I. MacDonald, Giorgia Isinelli,Maxence O. Dellacherie,Miguel Sobral,Haiqing Bai,Amanda R. Graveline,Andyna Vernet, Melinda Sanchez,
GENES & DEVELOPMENTno. 5-6 (2024): 289-289
Bone Marrow Transplantationno. 5 (2024): 1-8
Load More
Author Statistics
#Papers: 1338
#Citation: 98565
H-Index: 154
G-Index: 292
Sociability: 9
Diversity: 0
Activity: 9
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn